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Using immunohistochemistry at the conventional light, confocal and electron
microscopic levels, we have demonstrated that rat stomach ECL cells store his-
tamine and pancreastatin in granules and secretory vesicles, while histidine
decarboxylase occurs in the cytosol. Furthermore the ECL cells display
immunoreactivity for vesicular monoamine transporter type 2 (VMAT-2),
synaptophysin, synaptotagmin III, vesicle-associated membrane protein-2, cys-
teine string protein, synaptosomal-associated protein of 25 kDa, syntaxin and
Munc-18. Using electron microscopy in combination with stereological methods,
we have evidence to suggest the existence of both an exocytotic and a
crinophagic pathway in the ECL cells. The process of exocytosis in the ECL
cells seems to involve a class of proteins that promote or participate in the
fusion between the granule/vesicle membrane and the plasma membrane. The
granules take up histamine by VMAT-2 from the cytosol during transport from
the Golgi zone to the more peripheral parts of the cells. As a result, they turn
into secretory vesicles. As a consequence of stimulation (e.g., by gastrin), the
secretory vesicles fuse with the cell membrane to release their contents by exo-
cytosis. The crinophagic pathway was studied in hypergastrinemic rats. In the
ECL cells of such animals, the secretory vesicles were found to fuse not only
with the cell membrane but also with each other to form vacuoles. Subsequent
lysosomal degradation of the vacuoles and their contents resulted in the devel-
opment oflipofuscin bodies.
INTRODUCTION
The mucosa ofthe digestive tract is rich in endocrine cells, which have been classified
into enterochromaffin and enterochromaffin-like cells. They can be collectively demonstrated
by so-called argyrophil staining techniques. The enterochromaffin cells contain serotonin
orcatecholamines, which accounts for the fact that they can be stained with chromaffin or
argentaffin staining techniques. The enterochromaffin-like cells do not contain serotonin or
catecholamines and cannot be stained with chromaffin or argentaffin staining techniques.
Like the enterochromaffin cells, they have the capacity to convert DOPA or 5-HTP to
dopamine and serotonin, respectively, and to store the amine in the secretory granules for
some time. The term enterochromaffln-like derives from the fact that afterthese cells have
been induced to store monoamines they are structurally and histochemically indistin-
guishable from the enterochromaffin cells [1]. The oxyntic mucosa of the rat stomach is
rich in enterochromaffln-like cells [1]. They comprise several distinct cell types: ECLcells,
A-like cells, D cells and D1/P cells. This classification is based on the ultrastructural char-
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acteristics ofthe different cell types [2, 3]. The ECLcells have an irregular, slender shape,
sometimes with quite long extensions, and the cytoplasm contains numerous, quite large
electron-lucent vesicles and a few, small electron-dense granules [4, 5].
Due to their content of histamine and of the histamine-forming enzyme histidine
decarboxylase (HDC), the ECL cells can be demonstrated by immunocytochemistry
using antibodies to histamine [6] or to the HDC [7]. In addition, the ECL cells are known
to display immunoreactivity for chromogranin A-derived peptides such as pancreastatin
[6, 8-11]. Of the various endocrine cells (enterochromaffin and enterochromaffin-like
cells) in the oxyntic mucosa, only the ECL cells produce histamine [6, 7, 12, 13] and
respond to gastrin by the release of histamine [11, 14-16], which mediates the gastrin-
induced stimulation of acid secretion from the parietal cells [17, 18]. The ECL cells
respond to gastrin according to a precise time- table [19, 20]. Among acute effects (man-
ifested within minutes) are the release of histamine and pancreastatin [11]. Among less
immediate effects (within hours) are those manifested first in the activation of HDC and
subsequently in the increased expression ofHDC mRNA [11]. Long-term effects ofhyper-
gastrinemia include hypertrophy (after several days of hypergastrinemia), hyperplasia
(after weeks ofhypergastrinemia), and dysplasia/neoplasia (after one to two years) [21, 22].
HISTAMINE, PANCREASTATIN AND
EXOCYTOTIC PROTEINS IN ECL CELLS
Light microscopy
The ECL cells are numerous in the oxyntic mucosa ofrat, mouse and hamster, while
mast cells are comparatively few. In these species, histamine immunostaining provides an
excellent method for the demonstration of ECL cells. In mammals, the ECL cells are
restricted to the oxyntic mucosa and occur in the basal half of the mucosa (Figure 1).
Double immunostaining with antibodies against HDC and vesicular monoamine trans-
porter type 2 (VMAT-2) revealed the presence of VMAT-2 immunoreactivity in the ECL
cells (Figure 2). The protein-protein interactions behind the intracellular transport ofcyto-
plasmic organelles and behind the process of exocytosis has been extensively studied in
neurons. TheECLcells werefoundtodisplay immunoreactivity forsynaptophysin (Figure 3),
synaptotagmin III, vesicle-associated membrane protein-2 (VAMP-2), cysteine string pro-
tein (CSP), synaptosomal-associated protein of25 kDa(SNAP-25), syntaxin andMunc-18,
Figure 1. Immunofluorescence photo-
micrograph of rat oxyntic mucosa
afterstaining with antiserum to hista-
mine. Numerous immnunoreactive ECL
cells in the basal part ofthe glands, scat-
tered imnunoreative mast cells at the
mucosal surface and in the submucosa.
> _SS ~~~~~~~~~Bar = 50 ,um.
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but not for synaptotagmin I/II and VAMP-1 [23]. These findings suggest that the proteins
that promote or participate in the docking and fusion of granules/vesicles to the plasma
membrane are similar in neurons and ECL cells.
. Confocal mleroscopy
The precise subcellular localization ofECLcell histamine remains unknown. The failure
to demonstrate histamine at the subcellular level, e.g., by immunoelectron microscopy,
may reflect the diffusion ofhistamine from its storage site because ofinadequate fixation or
because ofthe destruction ofthe antibody-recognizing epitopes by the fixation. By confocal
microscopy of immunostained section we were able to show that histamine is present
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Figure 2. Immunofluorescence photomicrographs ofrat oxyntic mucosa after double-labeling
with antisera to VMAT-2 (a) and histidine decarboxylase (HDC) (b). VMAT-2 immunoreactivi-
ty is present in all HDC-positive ECLcells (arrowheads) and in non-ECLcells as well. Bar = 25 ,um.
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Figure 3. Immunofluorescence photomicrographs ofrat oxyntic mucosa after double-labeling
with antisera to synaptophysin (a) and histidine decarboxylase (HDC) (b). Synaptophysin
immunoreactivity is present in all HDC-positive ECL cells (arrowheads). Arrows indicate synapto-
physin-positive nerve Elbers. Bar= 25 ,um.
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Figure 4. Confocal immunofluorescence
photomicrographs of rat oxyntic mucosa
after staining with antiserum to histamine
(a) and after double-labeling with antisera
to pancreastatin and histidine decarboxy-
lase (HDC) (b). Histamine immunoreactivity
(red fluorescence) has punctate localization
to granules/vesicles (arrowheads) and in the
cytosol (arrows). Pancreastatin immunoreactiv-
ity (red fluorescence) has a punctate localiza-
tion to granules/vesicles (arrowheads) while
HDC immunoreactivity (green fluorescence)
is in the cytosol (arrows). Bar = 10 jim.
both in the cytosol and in the secretory vesicles but usually at a much higher concentration
in the latter site. HDC immunoreactivity was found to occur in the cytosol only (Figure 4).
Electron microscopy
ECL cells have been identified as the only endocrine cell type in rat oxyntic mucosa
that contains histamine by electron microscopic immunocytochemistry for histamine [12].
The ECL cells contain not only histamine but also pancreastatin. In fact, the ECL cells are
the main source ofcirculatingpancreastatin in the rat [24-26]. Pancreastatin is derived from
chromogranin A. Chromogranin/pancreastatin is probably synthesized, packaged, stored,
processed and secreted in parallel with the anticipated ECL cell-peptide hormone. The
gastrin-induced release of pancreastatin parallels that of histamine, while pancreastatin
can be released independently ofhistamine, for instance, afterblocking histamine synthesis
[27]. At the electron microscopic level, we could show that ECLcell-pancreastatin occurs in
the dense cores ofthe granules/vesicles (Figure 5). We suggest that the electron dense parts
of the organelles are the storage site for pancreastatin and other secretory peptides and
proteins while the electron lucentparts oftheorganelles represent the storage site forhistamine.
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T . ' ..,-.! .... '.... Figure 5. Immuno-electron micrograph
showingtheenterochromaffin-likecell ultra-
structure after staining with antiserum to
*
s) - ; iZ bpancreastatin. Pancreastatin immunoreactiv-
ity,revealedbyimmunogoldstaining, ispresent : : .]* ^ Z in the electron-dense cores (arrows) of the
' ''*',; . '-.i' - - i9.&.4'secretory vesicles (asterisks). Bar = 200 nm.
DYNAMICS OF ECL CELL GRANULES AND VESICLES
Classification oforganelles
The cytoplasm of the ECL cells is rich in fairly large, electron-lucent vesicles, which
have a small and eccentrically located dense core (Figure 6). In addition, a few granules
with prominent electron-dense core and a few clear microvesicles can be observed. In the
case oflong-term hypergastrinemia, the ECL cells display very large vesicles and electron
dense bodies in their cytoplasm. We have classified the various organelles into granules,
secretory vesicles, microvesicles, vacuoles and lipofuscin bodies (Figure 7) [28, 29]. The
granules are defined ascytoplasmic membrane-enclosedorganelles (with adiameter of25-
200 nim), displaying an electron-dense core and a thin electron-lucent halo between the
membrane and the dense core, the diameter of the dense core representing more than 50
percent ofthe diameter ofthe entireorganelle. The vesicles are membrane-enclosed electron-
lucent organelles without a dense core or possessing a small, often eccentrically located
dense core, the diameter ofthe dense core being less than 50 percent ofthe diameter ofthe
Figure 6. Electron micrograph
ltl_lF i!fof an ECL cell with typical
- ~~~~~~~~~~~~~secretory vesicles and a few
granules (arrows). Bar = 1 gm.
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Figure 7. Electron micrographs of ECL cells showing granules (a, arrows), microvesicles (b,
arrows), secretory vesicles (c, arrows), vacuoles (d, black asterisk) and lipofuscin bodies (d,
white asterisks). Note, in b, a typical clathrin-coated vesicle indicated by a triangle. a-c Control
rats, d Omeprazole-treated rat (10 weeks of daily administration of the drug). Bar in d = 200 nm.
organelle. Based on profile size, vesicles belong to one of three populations: 1) secretory
vesicles with a diameter of 125-500 nm (with a dense core, which can be revealed by serial
sectioning if not immediately apparent); 2) vacuoles with a diameter of at least 500 nm
without visible dense core orpossessing one (or more than one) dense core; and 3) electron-
lucent microvesicles with a diameter of 25-125 nm. Lipofuscin bodies are identified by
their irregular shape and high electron density (osmiophilia).
We have proposed a model for the development and maturation of secretory
organelles and for the mechanism behind the fusion ofmembranes in these cells [11, 30].
The granules with their content ofchromograninAandpeptide hormone precursorbud off
from the Golgi apparatus and start to take up histamine during their transport to the more
peripheral parts ofthe cells. As aresult, they turn into secretory vesicles, possibly through
osmotic forces, generated by the progressive accumulation of histamine and other small
molecules. Among small molecules that will accumulate in the secretory vesicles are
cleavage products of chromogranin A (e.g., pancreastatin) and of the anticipated peptide
hormone precursor, which are generated by proteolysis within the granules. According to
this concept, we should expect the secretory vesicles to represent areadily releasable pool of
histamine and other secretory products, while the granules should represent a less readily
releasable pool. As a consequence of stimulation, the secretory vesicles fuse with the cell
222Chen et al.: ECL cell morphology 223
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Figure 8. Histamine concentration in the oxyntic mucosa and number ofsecretory vesicles per
ECL cell in the stomach ofmice, rats and hamsters that were treated with vehicle (control) or
a-FMH for 24 hr. Mean ± SEM (vertical bars, n = 7-8 animals and 36-41 cells in each group).
membrane to release their contents by exocytosis [11]. The microvesicles become numerous,
perhaps as a result ofstimulated recycling, which can be expected to lead to an increased
number of retrieval vesicles [22]. Gastrin accelerates several of the steps that control the
formation and subsequent maturation ofthe storage/secretory organelles, namely the for-
mation ofgranules, theirtransformation into secretory vesicles, the excytosis andendocytosis
(resulting in microvesicles), and the fusion of secretory vesicles with each other (resulting
in vacuoles). Vacuoles and lysosomes probably play a role in the degradation ofsuperfluous
products (granule disposal or crinophagia). The highly electron dense material that accu-
mulates within the lumen oflysosomes as a result ofautophagic degradation is referred to
as ceroid or lipofuscin (age pigment) [31-33]. We interpret the vacuoles and lipofuscin
bodies that appear in ECL cells in response to long-term hypergastrinemia as crinophagic
(autophagic) organelles.
Development ofgranules into secretory vesicles
a-Fluoromethylhistidine (a-FMH) is an irreversible and selective inhibitor of HDC
[34]. Treatment with ax-FMH results in a loss of 65 to 90 percent of the histamine in the
oxyntic mucosa of mouse, rat and hamster, and the number of secretory vesicles in the
ECL cells is reduced in parallel (Figure 8) [see also 13, 28, 35]. VMAT-2 has been found
to exist in ECL cell granules/vesicles. Histamine is thought to accumulate in
granules/secretory vesicles through action ofVMAT-2. This transporter can be blocked by
reserpine. Treatment with reserpine reduced greatly the number oflarge secretory vesicles
while increasing the numberofgranules (Figure 9). The combination ofgastrin andreserpine
still reduced the number of large secretory vesicles but increased greatly the number of
granules (Figure 10). Together, these findings support our hypotheses 1) that pre-formed
histamine in the cytosol is taken up by granules, probably via VMAT-2 and 2) that the
accumulation ofhistamine is necessary for transforming granules into secretory vesicles.Chen et al.: ECL cell morphology
Figure 9. Electron micrographs showing ECLcells from a control rat (a) and from a rattreated
with reserpine for two days (25 mg/kg i.p. once perday) (b). Numerous granules and few secretory
vesicles in b. Bar in b = 1000 nm.
Figure 10. Electron micrographs showing ECL cells of rats treated with gastrin for 4 days (a)
or gastrin for 4 days plus reserpine for the last 2 days (b). Note that afterreserpine, large secre-
tory vesicles are missing and vacuoles fail to develop in response to gastrin (b). Bar in b = 700 nm.
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Figure 11. Electron micrograph
showing (a) a vacuole (asterisk)
and numerous secretory vesicles
(arrows), and (b) a vacuole
(asterisk)withmembraneresidues
(arrows). The two vacuoles gives
the impression of being engaged
in fusion (a) and having been
engaged in fusion (b). Bar in b =
200 nm.
Figure 12. Two consec-
utive sections of a seri-
ally sectioned ECL cell
from an omeprazole-
treated rat (6 weeks of
treatment)revealing two
electron-dense cores (ar-
rows) (b) in a vacuole
that appeared to be
empty when examined
in the previous section
(a). The vacuole in (a)
appears as two vacuoles
in (b) (asterisks). Bar in
b = 300 nm.
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Figure 13. Electron
micrographs showing
ECL cells from an
omeprazole-treated
rat (a) and from an a-
*FMH and omepra-
zole- treated rat (b).
Following omeprazole
treatment (six weeks of
treatment), granules are
scarce, secretory vesi-
cles (arrows) are fairly
numnrous and vacuoles
are prominent (aster-
isks). a-FMH treat-
ment eliminates the
fusion. The secretory vesicles and
vacuoles. Bar in bo
vacuoles lipofuscin bodies
8-
4-2
0
~2-
0 Th9 O
-1 0 1 2 3 4 5 6 -1 0 1 2 3 4 5 6
Days ofgastrin infusion
Figure 14. Time course of change in volume densities of vacuoles and of lipofuscin bodies in
response to continuous, subcutaneous infusion ofgastrin over a time period ofsix days. Mean
+ SEM (n = 6-7 rats and 30-35 cells in each group).
Development ofsecretory vesicles into vacuoles
Vacuoles occur in response to long-term sustained hypergastrinemia induced by gas-
trin infusion or by treatment with gastric acid inhibitors such as omeprazole [22, 28, 36-
38]. Their appearance is associated with a decrease in the number and volume density of
the secretory vesicles. Conceivably, vacuoles arise as a result of the gastrin-evoked acti-
vation of the enterochromaffiln-like cells, perhaps because the stimuli that induce intracel-
lular membrane-membrane interactions result not only in exocytosis but also in vesicle
fusion. The secretory vesicles in many of these cells line up in long rows or form aggre-
gates, and the vesicles are often in such intimate contact that they give the impression of
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Figure 15. Volume densities of vacuoles and lipofuscin bodies in rats treated with vehicle, a-
FMH (FMH), omeprazole (OME), or OME plus FMH for six weeks. Omeprazole treatment
causes vacuoles and lipofuscin bodies to develop. a-FMH prevents this. Mean + SEM (n = 8-9 rats
and 30-35 cells). ** for p < .01; - in A and C = zero.
Figure 16. Electron micrograph suggesting that vacuoles (asterisks) and lipofuscin-containing
secondary lysosomes may fuse (arrow). Omeprazole-treated rat (10 weeks of treatment). Bar =
300 nm.
being engaged in fusion (Figure 11). The following additional findings support the view
that they result from the fusion of several secretory vesicles, namely 1) that the vacuoles
at times contain more than one dense core (Figure 12) and 2) that a-FMH or reserpine
treatment prevented the formation ofvacuoles, conceivably by preventing orimpairing the
formation of secretory vesicles (Figure 13).
Development ofvacuoles into lipofuscin
The increased numberandvolume density ofvacuoles was associatedwith anincreased
number and volume density oflipofuscin bodies in the ECL cell cytoplasm in response to
sustained gastrin stimulation (Figure 14). There was a good correlation between the number
of vacuoles and of lipofuscin bodies (r = .965, p < .001) [29]. a-FMH-evoked ECL cell
histamine depletion prevented the formation ofvacuoles and also the development oflipo-
fuscin (Figure 15). These observations indicate that vacuoles contribute to the formation of
X 10
amO
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Exocytotic pathway
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Figure 17. Schematic drawing ofthe proposed exocytotic pathway ofthe ECLcells (fordetails,
see text). Rectangle indicates thathistamine is stored in the electron lucent part, whilepancreastatin
is in the electron dense part.
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Figure 18. Schematic drawing of the suggested localization of different exocytotic proteins.
Synaptophysin, VAMP and synaptotagmin III are all proteins that have transmembrane domains,
which anchors them to the secretory vesicle membrane. CSPhas so faronly been shown to be asso-
ciated with granules/secretory vesicles. SNAP-25 and syntaxin are associated with theplasma mem-
brane, where syntaxin has a close relationship with calcium-channels. Munc-18 is located in the
cytoplasm and has been shown to interact with syntaxin. Histamine is synthesized in the cytoplasm
from histidine via the enzyme histidine decarboxylase (HDC), and is thereafter taken up via VMAT-
2, located at the membrane of the granules/vesicles.
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Crinophagic pathway
Secretory vesiles
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* Lysosomalcompartment
Lipofuscinbod
Figure 19. Schematic drawing ofthe proposed crinophagic pathway in the enterochromaffin-
like cells (for details, see text).
lipofuscin. In ECL cells ofhypergastrinemic rats, membrane-membrane fusion was seen
not only between the secretory vesicles (resulting in vacuoles) but also between vacuoles
and lipofuscin-containing secondary lysosomes (Figure 16). The findings are in line with
the view that vacuoles form part of the lysosomal compartment. In fact, it has been sug-
gested previously that material within lysosomal membrane-bound vacuoles (secondary
lysosomes) can aggregate or disperse through fusion and fission [32, 39].
SUMMARY
1. Exocytotic pathway. The granules bud off from the Golgi apparatus. The intra-
granular proteins condense in the process, forming an electron-dense core. The newly
formed granules take up histamine from the cytosol by VMAT-2 during their transport
from the Golgi area to the more peripheral parts ofthe cells. As aresult, the granules turn
into secretory vesicles. The secretory vesicles represent areadily releasable pool ofsecretory
products.As aconsequence ofstimulation, the secretory vesicles fuse withthecellmembrane
to release their contents by exocytosis (Figure 17). The ECL cells are rich in exocytotic
proteins that promote granule/vesicle docking and fusion with the plasma membrane.
Synaptophysin and VAMP-2 are vesicle proteins that participate in the docking of the
organelle to the cell membrane. They bind to proteins in the cell membrane, such as
SNAP-25 and syntaxin; cytosolic Munc-18 binds to syntaxin. The process offusion ofthe
secretory organelle with the cell membrane probably involves the interaction of synapto-
tagmin III, syntaxin and CSP with Ca2+ channels (Figure 18).
2. Crinophagic pathway. Long-lasting hypergastrinemia stimulates the development
of vacuoles, which are formed by the fusion of several secretory vesicles. The develop-
ment of vacuoles is associated with the development of lipofuscin bodies. The latter
organelles probably result from lysosomal degradation ofthe vacuoles and their contents.
The lipofuscin bodies contain the indigestible waste products of autophagia (Figure 19).
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